Thomas Mika Katharina Strate Swetlana Ladigan Clemens Aigner Uwe Schlegel Iris Tischoff Sabine Tischer-Zimmermann Britta Eiz-Vesper Britta Maecker-Kolhoff Roland Schroers
10.3389/fmed.2019.00295
Front Med (Lausanne)
2019 Dec 18;6:295.
ptld aggressive lymphoma allohsct brentuximab vedotin (bv) third-party ebv-specific t-lymphocytes
CC BY
https://pubmed.ncbi.nlm.nih.gov/31921871/
Case Reports
PMC6930172
31921871
Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
2019